| For: | Salcido-Neyoy ME, Sierra-Santoyo A, Beltrán-Ramírez O, Macías-Pérez JR, Villa-Treviño S. Celecoxib enhances the detoxification of diethylnitrosamine in rat liver cancer. World J Gastroenterol 2009; 15(19): 2345-2350 [PMID: 19452576 DOI: 10.3748/wjg.15.2345] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v15/i19/2345.htm |
| Number | Citing Articles |
| 1 |
Mohamed I.F. Shariff, Joshua M. Tognarelli, Matthew R. Lewis, Elizabeth J. Want, Fatma El Zahra Mohamed, Nimzing G. Ladep, Mary M.E. Crossey, Shahid A. Khan, Rajiv Jalan, Elaine Holmes, Simon D. Taylor-Robinson. Plasma Lipid Profiling in a Rat Model of Hepatocellular Carcinoma: Potential Modulation Through Quinolone Administration. Journal of Clinical and Experimental Hepatology 2015; 5(4) doi: 10.1016/j.jceh.2015.07.205
|
| 2 |
Jaime Arellanes-Robledo, Martha Estela Salcido-Neyoy, Adriana Márquez-Quiñones, Rebeca García-Román, Olga Beltrán-Ramírez, Véronique Le Berre, Sergueï Sokol, Jean Marie François, Saúl Villa-Treviño. Celecoxib activates Stat5 and restores or increases the expression of growth hormone-regulated genes in hepatocarcinogenesis. Anti-Cancer Drugs 2010; 21(4) doi: 10.1097/CAD.0b013e328336e907
|
| 3 |
Suresh Kumar Nayudu, Shanti Badipatla, Masooma Niazi, Bhavna Balar. Cholestatic Hepatitis with Small Duct Injury Associated with Celecoxib. Case Reports in Medicine 2013; 2013 doi: 10.1155/2013/315479
|
| 4 |
Ekaterina A. Korobkova. Effect of Natural Polyphenols on CYP Metabolism: Implications for Diseases. Chemical Research in Toxicology 2015; 28(7) doi: 10.1021/acs.chemrestox.5b00121
|
| 5 |
Chun-Chieh Yeh, Pei-Ying Liao, Sudhir Pandey, Su-Yung Yung, Hsueh-Chou Lai, Long-Bin Jeng, Wei-Chun Chang, Wen-Lung Ma. Metronomic Celecoxib Therapy in Clinically Available Dosage Ablates Hepatocellular Carcinoma via Suppressing Cell Invasion, Growth, and Stemness in Pre-Clinical Models. Frontiers in Oncology 2020; 10 doi: 10.3389/fonc.2020.572861
|
| 6 |
Olga Beltrán-Ramírez, Roberto Macías Pérez, Adolfo Sierra-Santoyo, Saúl Villa-Treviño. Cancer Prevention Mediated by Caffeic Acid Phenethyl Ester Involves Cyp2b1/2 Modulation in Hepatocarcinogenesis. Toxicologic Pathology 2012; 40(3) doi: 10.1177/0192623311431947
|
| 7 |
Brisa Rodope Alarcón-Sánchez, Julio Isael Pérez-Carreón, Saúl Villa-Treviño, Jaime Arellanes-Robledo. Molecular alterations that precede the establishment of the hallmarks of cancer: An approach on the prevention of hepatocarcinogenesis. Biochemical Pharmacology 2021; 194 doi: 10.1016/j.bcp.2021.114818
|
| 8 |
Larissa Widholzer Galant, Ângelo Alves de Mattos, Eduardo Menti, Fabiana Borba Valiatti, Ângelo Zambam de Mattos, Marilene Porawski, Antônio Hartmann, Cláudia Ramos Rhoden. The effect of celecoxib on the development of diethylnitrosamine-induced liver tumors in rats. Annals of Hepatology 2013; 12(3) doi: 10.1016/S1665-2681(19)31005-1
|
| 9 |
Jian Chen, Peng Shen, Xiao-chen Zhang, Meng-dan Zhao, Xing-guo Zhang, Liu Yang. Efficacy and Safety Profile of Celecoxib for Treating Advanced Cancers: A Meta-analysis of 11 Randomized Clinical Trials. Clinical Therapeutics 2014; 36(8) doi: 10.1016/j.clinthera.2014.06.015
|